{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T18:41:31Z","timestamp":1771526491807,"version":"3.50.1"},"publisher-location":"New York, NY","reference-count":25,"publisher":"Springer New York","isbn-type":[{"value":"9781493933853","type":"print"},{"value":"9781493933877","type":"electronic"}],"license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016]]},"DOI":"10.1007\/978-1-4939-3387-7_27","type":"book-chapter","created":{"date-parts":[[2016,4,14]],"date-time":"2016-04-14T11:08:16Z","timestamp":1460632096000},"page":"487-498","source":"Crossref","is-referenced-by-count":10,"title":["Assessment of Live Plague Vaccine Candidates"],"prefix":"10.1007","author":[{"given":"Valentina A.","family":"Feodorova","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lidiya V.","family":"Sayapina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vladimir L.","family":"Motin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,4,14]]},"reference":[{"key":"27_CR1","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1128\/CMR.10.1.35","volume":"10","author":"RD Perry","year":"1997","unstructured":"Perry RD, Fetherston JD (1997) Yersinia pestis\u2014etiologic agent of plague. Clin Microbiol Rev 10:35\u201366","journal-title":"Clin Microbiol Rev"},{"key":"27_CR2","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1586\/erv.09.129","volume":"8","author":"VA Feodorova","year":"2009","unstructured":"Feodorova VA, Corbel MJ (2009) Prospects for new plague vaccines. Expert Rev Vaccines 8:1721\u20131738","journal-title":"Expert Rev Vaccines"},{"key":"27_CR3","doi-asserted-by":"publisher","DOI":"10.1038\/emi.2012.34","volume":"1","author":"VA Feodorova","year":"2012","unstructured":"Feodorova VA, Motin VL (2012) Plague vaccines: current developments and future perspectives. Emerg Microb Infect 1, e36","journal-title":"Emerg Microb Infect"},{"key":"27_CR4","first-page":"176","volume-title":"Vaccines against bacterial biothreat pathogens","author":"VA Feodorova","year":"2011","unstructured":"Feodorova VA, Motin VL (2011) Plague vaccines. In: Feodorova VA, Motin VL (eds) Vaccines against bacterial biothreat pathogens. Research Signpost, Kerala, pp 176\u2013233"},{"key":"27_CR5","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/0882-4010(92)90050-X","volume":"12","author":"VL Motin","year":"1992","unstructured":"Motin VL, Pokrovskaya MS, Telepnev MV et al (1992) The difference in the lcrV sequences between Yersinia pestis and Yersinia pseudotuberculosis and its application for characterization of Y. pseudotuberculosis strains. Microb Pathog 12:165\u2013175","journal-title":"Microb Pathog"},{"key":"27_CR6","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.meegid.2009.10.003","volume":"10","author":"AP Anisimov","year":"2010","unstructured":"Anisimov AP, Dentovskaya SV, Panfertsev EA et al (2010) Amino acid and structural variability of Yersinia pestis LcrV protein. Infect Genet Evol 10:137\u2013145","journal-title":"Infect Genet Evol"},{"key":"27_CR7","doi-asserted-by":"crossref","first-page":"4580","DOI":"10.1128\/IAI.64.11.4580-4585.1996","volume":"64","author":"GW Anderson","year":"1996","unstructured":"Anderson GW, Leary SEC, Williamson ED et al (1996) Recombinant V antigen protects mice against pneumonic and bubonic plague caused by F1-capsule-positive and -negative strains of Yersinia pestis. Infect Immun 64:4580\u20134585","journal-title":"Infect Immun"},{"key":"27_CR8","first-page":"156","volume":"120","author":"KJ Davis","year":"1996","unstructured":"Davis KJ, Fritz DL, Pitt ML et al (1996) Pathology of experimental pneumonic plague produced by fraction 1-positive and fraction 1-negative Yersinia pestis in African green monkeys (Cercopithecus aethiops). Arch Pathol Lab Med 120:156\u2013163","journal-title":"Arch Pathol Lab Med"},{"key":"27_CR9","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1586\/14760584.7.2.209","volume":"7","author":"ST Smiley","year":"2008","unstructured":"Smiley ST (2008) Current challenges in the development of vaccines for pneumonic plague. Expert Rev Vaccines 7:209\u2013221","journal-title":"Expert Rev Vaccines"},{"key":"27_CR10","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1111\/j.1600-065X.2008.00674.x","volume":"225","author":"ST Smiley","year":"2008","unstructured":"Smiley ST (2008) Immune defense against pneumonic plague. Immunol Rev 225:256\u2013271","journal-title":"Immunol Rev"},{"key":"27_CR11","doi-asserted-by":"publisher","first-page":"365980","DOI":"10.1155\/2012\/365980","volume":"2012","author":"ED Williamson","year":"2012","unstructured":"Williamson ED (2012) The role of immune correlates and surrogate markers in the development of vaccines and immunotherapies for plague. Adv Prev Med 2012:365980","journal-title":"Adv Prev Med"},{"key":"27_CR12","first-page":"3","volume":"6","author":"RA Saltykova","year":"1975","unstructured":"Saltykova RA, Faibich MM (1975) Experience from a 30-year study of the stability of the properties of the plague vaccine strain EV in the USSR. Zh Mikrobiol Epidemiol Immunobiol 6:3\u20138","journal-title":"Zh Mikrobiol Epidemiol Immunobiol"},{"key":"27_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/emi.2014.82","volume":"3","author":"VA Feodorova","year":"2014","unstructured":"Feodorova VA, Sayapina LV, Corbel MJ, Motin VL (2014) Russian vaccines against especially dangerous bacterial pathogens. Emerg Microb Infect 3, e86","journal-title":"Emerg Microb Infect"},{"key":"27_CR14","first-page":"631","volume":"52","author":"G Girard","year":"1963","unstructured":"Girard G (1963) Immunity in plague infection. Results of 30 years of work with the Pasteurella pestis EV strain (Girard and Robic). Biol Med 52:631\u2013731","journal-title":"Biol Med"},{"issue":"Suppl","key":"27_CR15","doi-asserted-by":"publisher","first-page":"S85","DOI":"10.1093\/infdis\/129.Supplement_1.S85","volume":"129","author":"KF Meyer","year":"1974","unstructured":"Meyer KF, Smith G, Foster L et al (1974) Live, attenuated Yersinia pestis vaccine: virulent in nonhuman primates, harmless to guinea pigs. J Infect Dis 129(Suppl):S85\u2013S112","journal-title":"J Infect Dis"},{"key":"27_CR16","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.meegid.2014.05.023","volume":"26","author":"Y Cui","year":"2014","unstructured":"Cui Y, Yang X, Xiao X et al (2014) Genetic variations of live attenuated plague vaccine strains (Yersinia pestis EV76 lineage) during laboratory passages in different countries. Infect Genet Evol 26:172\u2013179","journal-title":"Infect Genet Evol"},{"key":"27_CR17","doi-asserted-by":"publisher","first-page":"878","DOI":"10.2174\/1389201014666131226122243","volume":"14","author":"W Sun","year":"2013","unstructured":"Sun W, Curtiss R (2013) Rational considerations about development of live attenuated Yersinia pestis vaccines. Curr Pharm Biotechnol 14:878\u2013886","journal-title":"Curr Pharm Biotechnol"},{"key":"27_CR18","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1586\/erv.13.42","volume":"12","author":"X Wang","year":"2013","unstructured":"Wang X, Zhang X, Zhou D, Yang R (2013) Live-attenuated Yersinia pestis vaccines. Expert Rev Vaccines 12:677\u2013686","journal-title":"Expert Rev Vaccines"},{"key":"27_CR19","doi-asserted-by":"publisher","first-page":"7620","DOI":"10.1016\/j.vaccine.2007.08.055","volume":"25","author":"VA Feodorova","year":"2007","unstructured":"Feodorova VA, Pan\u2019kina LN, Savostina EP et al (2007) A Yersinia pestis lpxM-mutant live vaccine induces enhanced immunity against bubonic plague in mice and guinea pigs. Vaccine 25:7620\u20137628","journal-title":"Vaccine"},{"key":"27_CR20","doi-asserted-by":"publisher","first-page":"2240","DOI":"10.1016\/j.vaccine.2009.02.020","volume":"27","author":"VA Feodorova","year":"2009","unstructured":"Feodorova VA, Pan\u2019kina LN, Savostina EP et al (2009) Pleiotropic effects of the lpxM mutation in Yersinia pestis resulting in modification of the biosynthesis of major immunoreactive antigens. Vaccine 27:2240\u20132250","journal-title":"Vaccine"},{"key":"27_CR21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0007023","volume":"4","author":"A Tidhar","year":"2009","unstructured":"Tidhar A, Flashner Y, Cohen S et al (2009) The NlpD lipoprotein is a novel Yersinia pestis virulence factor essential for the development of plague. PLoS One 4, e7023","journal-title":"PLoS One"},{"key":"27_CR22","doi-asserted-by":"crossref","unstructured":"Dentovskaya SV, Ivanov SA, Kopylov PK et al (2015) Selective protective potency of Yersinia pestis DeltanlpD mutants. Acta Naturae 7:102\u2013108","DOI":"10.32607\/20758251-2015-7-1-102-108"},{"key":"27_CR23","doi-asserted-by":"publisher","first-page":"3552","DOI":"10.4161\/hv.35119","volume":"10","author":"G Tian","year":"2014","unstructured":"Tian G, Qi Z, Qiu Y et al (2014) Comparison of virulence between the Yersinia pestis Microtus 201, an avirulent strain to humans, and the vaccine strain EV in rhesus macaques, Macaca mulatta. Hum Vaccin Immunother 10:3552\u20133560","journal-title":"Hum Vaccin Immunother"},{"key":"27_CR24","unstructured":"Vaccine prophylaxis. Basic requirements for the vaccine strains of plague microbe (2002) Testing guidelines. MU 3.3.1.1113-02, Moscow (in Russian)"},{"key":"27_CR25","first-page":"473","volume-title":"Infectious disease","author":"VL Braciale","year":"2008","unstructured":"Braciale VL, Nash M, Sinha N et al (2008) Correlates of immunity elicited by live Yersinia pestis vaccine. In: Georgiev VS, Western K, McGowan JJ (eds) Infectious disease. Springer, Totowa, NJ, pp 473\u2013480"}],"container-title":["Methods in Molecular Biology","Vaccine Design"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-4939-3387-7_27","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,18]],"date-time":"2020-09-18T17:24:47Z","timestamp":1600449887000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-4939-3387-7_27"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"ISBN":["9781493933853","9781493933877"],"references-count":25,"URL":"https:\/\/doi.org\/10.1007\/978-1-4939-3387-7_27","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016]]}}}